Celltrion Gets Ready To Face The Competition After European Bevacizumab Nod

Vegzelma CT-P16 Biosimilar Rival To Avastin Receives CHMP Positive Opinion

Europe Map Crowd People
Celltrion faces a crowded European market for bevacizumab • Source: Shutterstock

More from Biosimilars

More from Products